Update History
Syndrome: Hereditary Hemorrhagic Telangiectasia
Gene/Gene Panel: ENG, ACVRL1, SMAD4, GDF2
Genboree Administrator Account
2018/11/01
Released
Anticipatory treatment to avoid CAVM-related morbidity (ACVRL1)
Cerebral MRI
8NB
Anticipatory treatment to avoid CAVM-related morbidity (ENG)
Cerebral MRI
9NB
Anticipatory treatment to avoid CAVM-related morbidity (GDF2)
Cerebral MRI
7DB
Anticipatory treatment to avoid CAVM-related morbidity (SMAD4)
Cerebral MRI
8NB
Anticipatory treatment to avoid PAVM-related morbidity (ACVRL1)
TTCE
10NB
Anticipatory treatment to avoid PAVM-related morbidity (ENG)
TTCE
11NB
Anticipatory treatment to avoid PAVM-related morbidity (GDF2)
TTCE
8DB
Anticipatory treatment to avoid PAVM-related morbidity (SMAD4)
TTCE
11NB
Internal system migration related to score text replacement from E to N
Liz Webber
2018/01/12
Released
Anticipatory treatment to avoid CAVM-related morbidity (ACVRL1)
Cerebral MRI
8EB
Anticipatory treatment to avoid CAVM-related morbidity (ENG)
Cerebral MRI
9EB
Anticipatory treatment to avoid CAVM-related morbidity (GDF2)
Cerebral MRI
7DB
Anticipatory treatment to avoid CAVM-related morbidity (SMAD4)
Cerebral MRI
8EB
Anticipatory treatment to avoid PAVM-related morbidity (ACVRL1)
TTCE
10EB
Anticipatory treatment to avoid PAVM-related morbidity (ENG)
TTCE
11EB
Anticipatory treatment to avoid PAVM-related morbidity (GDF2)
TTCE
8DB
Anticipatory treatment to avoid PAVM-related morbidity (SMAD4)
TTCE
11EB
Elizabeth Clarke
2017/10/23
Released
Anticipatory treatment to avoid CAVM-related morbidity (ACVRL1)
Cerebral MRI
8EB
Anticipatory treatment to avoid CAVM-related morbidity (ENG)
Cerebral MRI
9EB
Anticipatory treatment to avoid CAVM-related morbidity (GDF2)
Cerebral MRI
7DB
Anticipatory treatment to avoid CAVM-related morbidity (SMAD4)
Cerebral MRI
8EB
Anticipatory treatment to avoid PAVM-related morbidity (ACVRL1)
TTCE
10EB
Anticipatory treatment to avoid PAVM-related morbidity (ENG)
TTCE
11EB
Anticipatory treatment to avoid PAVM-related morbidity (GDF2)
TTCE
8DB
Anticipatory treatment to avoid PAVM-related morbidity (SMAD4)
TTCE
11EB